Gene · 5251
Papers1,921
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,921
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Safety, tolerability, pharmacokinetics, and efficacy of burosumab in infants with X-linked hypophosphataemia: an open-label, multicentre, non-randomised study. | Lancet Diabetes Endocrinol | 2026 | 42044650 | PubTator, text mining | PubMed |
| The PHEX deletion variant (p.Thr605MetfsTer14) causes X-linked hypophosphatemic rickets by reducing protein expression and promoting mineralization. | Orphanet J Rare Dis | 2026 | 42001164 | PubTator, text mining | PubMed |
| Association of PHEX Gene Dosage With Meniere Disease and Related Audiovestibular Phenotypes in X-Linked Hypophosphatemia. | JAMA Otolaryngol Head Neck Surg | 2026 | 41989789 | PubTator, text mining | PubMed |
| Case Report: A case of x-linked hypophosphatemic rickets complicated with polyostotic fibrous dysplasia caused by PHEX gene mutation and literature review. | Front Endocrinol (Lausanne) | 2026 | 41928886 | PubTator, text mining | PubMed |
| Integrating Network Pharmacology, Molecular Dynamics, Machine Learning, and Animal Experiments to Decipher the Anti-fibrotic Mechanism of BI 1015550 in Idiopathic Pulmonary Fibrosis. | Curr Comput Aided Drug Des | 2026 | 41926303 | PubTator, text mining | PubMed |
| Clinical features of Italian adult individuals with X-linked hypophosphatemia: a multicenter retrospective study. | Endocr Connect | 2026 | 41921026 | PubTator, text mining | PubMed |
| X-linked hypophosphatemia in the presence of a CLDN16 variant: implications for renal handling and disease severity. | JCEM Case Rep | 2026 | 41884086 | PubTator, text mining | PubMed |
| Integrating genetic counseling in endocrine practice: Prevention, reproductive care, and prenatal diagnosis. | Ann Endocrinol (Paris) | 2026 | 41864331 | PubTator, text mining | PubMed |
| The lived experience of adolescents with X-linked hypophosphataemia treated with burosumab at end of skeletal growth: a mixed-methods analysis. | PLoS One | 2026 | 41860923 | PubTator, text mining | PubMed |
| Bone matrix proteins: regulators of skeletal remodeling and repair. | J Bone Miner Metab | 2026 | 41832918 | PubTator, text mining | PubMed |
| Performance changes during and post-exercise in combined heat and hypoxia environments: a systematic review and network meta analysis. | J Transl Med | 2026 | 41826976 | PubTator, text mining | PubMed |
| A Japanese Patient With Craniosynostosis Due to X-Linked Hypophosphatemic Rickets Who Underwent Fronto-Orbital Distraction. | J Craniofac Surg | 2026 | 41823661 | PubTator, text mining | PubMed |
| Genetic background of infantile hypophosphatemia: a narrative review. | Transl Pediatr | 2026 | 41810186 | PubTator, text mining | PubMed |
| Postprandial serum phosphorus and calcium concentrations in adults and children with X-linked hypophosphatemia during burosumab treatment. | JBMR Plus | 2026 | 41777640 | PubTator, text mining | PubMed |
| Multi-omics and causal inference reveal lactylation-based osteoblast regulatory networks and drug candidates. | iScience | 2026 | 41736870 | PubTator, text mining | PubMed |
| Nanoparticles Targeting the Tumor Microenvironment for the Treatment of Osteosarcoma: Recent Progress and Perspectives. | Int J Nanomedicine | 2026 | 41725887 | PubTator, text mining | PubMed |
| Exploring Injectable Scaffolded Spheroids for Nucleus Pulposus Therapy in Degenerated Intervertebral Discs. | ACS Appl Mater Interfaces | 2026 | 41693133 | PubTator, text mining | PubMed |
| Autoimmune osteomalacia: a novel FGF23-related hypophosphatemic osteomalacia. | J Bone Miner Metab | 2026 | 41691126 | PubTator, text mining | PubMed |
| Animal-associated jumbo phages as widespread and active modulators of gut microbiome ecology and metabolism. | Sci Adv | 2026 | 41650276 | PubTator, text mining | PubMed |
| Burosumab in Unidentifiable Tumor-Induced Osteomalacia. | Clin Case Rep | 2026 | 41567527 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5251/papers?page=2